Muscle Mass Measurement On DEXA Predicts Mortality In Cardiac Surgery Patients: Study
- byDoctor News Daily Team
 - 08 July, 2025
 - 0 Comments
 - 0 Mins
 
                            
                                    Montreal: A recent study in the American Heart Journal showed that in older cardiac surgery patients, the measurements of muscle mass on dual-energy x-ray absorptiometry (DEXA) can help in predicting survival. The finding suggests measuring muscle mass provides valuable information for managing high-risk heart surgery patients.
"Lower-extremity muscle strength and dual x-ray absorptiometry (DXA)-based muscle mass are objective indicators of sarcopenia that are independently predictive of all-cause mortality in older cardiac surgery patients," wrote the authors.
Aayushi Joshi, Centre for Clinical Epidemiology, Jewish General Hospital, Montreal, QC, and colleagues determined the prevalence and prognostic value of sarcopenia measured by DXA and physical performance tests in patients undergoing coronary artery bypass surgery or heart valve procedures.
The researchers prospectively enrolled adults undergoing cardiac surgery. They completed a questionnaire, physical performance battery, and a DXA scan (GE Lunar) to measure appendicular muscle mass indexed to height2 (AMMI). Based on European Working Group 2 guidelines, they were categorized as sarcopenic if they had low AMMI defined as <7 kg/m2 for men or <5.5 kg/m2 for women, and low muscle strength defined as 5 chair rise time ≥15 seconds.
The cohort consisted of 141 patients with a mean age of 69.7 ± 10.0 years and 21% females.
The research yielded the following findings:
The prevalence rates of low AMMI, slow chair rise time, and sarcopenia (low AMMI and slow chair rise time) were 24%, 57%, 13%, respectively.
The 4-year survival rate was 79% in the non-sarcopenic group as compared to 56% in the sarcopenic group.
In the multivariable model, each standard deviation of decreasing AMMI and increasing chair rise time was associated with a hazard ratio for all-cause mortality of 1.84 and 1.79, respectively.
Sarcopenia (DXA-based low muscle mass and low muscle strength) is a valuable prognostic indicator of all-cause mortality after cardiac surgery, concluded the authors.
Reference:
The study titled, "Sarcopenia in cardiac surgery: Dual X-ray absorptiometry study from the McGill frailty registry," is published in the American Heart Journal.
DOI: https://www.sciencedirect.com/science/article/abs/pii/S0002870321001101
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Tags:
Recent News
Gum disease could silently cause serious brain dam...
- 03 November, 2025
 
Can Early-Day Fasting Significantly Boost Metaboli...
- 03 November, 2025
 
Delhi HC bars doctor from running medical centre d...
- 03 November, 2025
 
Phase III data for Gazyva/Gazyvaro show significan...
- 03 November, 2025
 
Daily Newsletter
Get all the top stories from Blogs to keep track.
                    
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!